Jane Street’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.4M Sell
694,684
-137,023
-16% -$9.34M ﹤0.01% 1357
2026
Q1
$53.8M Buy
831,707
+667,363
+406% +$47M 0.01% 1012
2025
Q4
$11.1M Sell
164,344
-911,024
-85% -$61.3M ﹤0.01% 2207
2025
Q3
$78.9M Buy
1,075,368
+108,392
+11% +$7.2M 0.01% 701
2025
Q2
$50.3M Buy
966,976
+926,602
+2,295% +$52.7M 0.01% 759
2025
Q1
$2.58M Sell
40,374
-15,796
-28% -$918K ﹤0.01% 3950
2024
Q4
$2.69M Sell
56,170
-122,132
-68% -$6.26M ﹤0.01% 3625
2024
Q3
$10.2M Sell
178,302
-113,195
-39% -$6.49M ﹤0.01% 1895
2024
Q2
$15.3M Buy
291,497
+190,324
+188% +$8.35M ﹤0.01% 1562
2024
Q1
$4.12M Sell
101,173
-58,330
-37% -$2.19M ﹤0.01% 2920
2023
Q4
$5.9M Sell
159,503
-29,759
-16% -$1.12M ﹤0.01% 2624
2023
Q3
$7.23M Buy
189,262
+16,010
+9% +$656K ﹤0.01% 2148
2023
Q2
$6.25M Buy
173,252
+11,423
+7% +$390K ﹤0.01% 2447
2023
Q1
$6.18M Buy
161,829
+92,121
+132% +$4.32M ﹤0.01% 2165
2022
Q4
$3.97M Buy
69,708
+16,477
+31% +$844K ﹤0.01% 2803
2022
Q3
$2.1M Sell
53,231
-132,546
-71% -$5.86M ﹤0.01% 4126
2022
Q2
$8.17M Buy
185,777
+148,432
+397% +$6.42M ﹤0.01% 1989
2022
Q1
$1.49M Buy
37,345
+14,315
+62% +$510K ﹤0.01% 5313
2021
Q4
$926K Buy
23,030
+15,278
+197% +$570K ﹤0.01% 6045
2021
Q3
$315K Buy
7,752
+2,526
+48% +$106K ﹤0.01% 8087
2021
Q2
$237K Sell
5,226
-72,351
-93% -$3.2M ﹤0.01% 8558
2021
Q1
$3.23M Sell
77,577
-5,829
-7% -$266K ﹤0.01% 3106
2020
Q4
$3.56M Buy
83,406
+40,795
+96% +$1.47M ﹤0.01% 2570
2020
Q3
$1.12M Buy
42,611
+26,400
+163% +$735K ﹤0.01% 3913
2020
Q2
$435K Buy
+16,211
New +$366K ﹤0.01% 5283
2020
Q1
Sell
-32,357
Closed -$614K 5576
2019
Q4
$574K Buy
32,357
+12,390
+62% +$215K ﹤0.01% 3514
2019
Q3
$310K Buy
+19,967
New +$329K ﹤0.01% 4140
2019
Q2
Sell
-17,986
Closed -$290K 5370
2019
Q1
$290K Buy
+17,986
New +$291K ﹤0.01% 4288
2018
Q4
Sell
-33,920
Closed -$616K 5245
2018
Q3
$616K Buy
+33,920
New +$594K ﹤0.01% 3359
2018
Q2
Sell
-13,829
Closed -$271K 5204
2018
Q1
$271K Sell
13,829
-13,647
-50% -$264K ﹤0.01% 4138
2017
Q4
$557K Buy
27,476
+4,029
+17% +$74.1K ﹤0.01% 3040
2017
Q3
$407K Sell
23,447
-2,564
-10% -$34.7K ﹤0.01% 3355
2017
Q2
$333K Buy
+26,011
New +$347K ﹤0.01% 3490
2016
Q3
Sell
-19,902
Closed -$172K 4195
2016
Q2
$172K Sell
19,902
-1,403
-7% -$13.8K ﹤0.01% 3800
2016
Q1
$202K Buy
+21,305
New +$200K ﹤0.01% 3705
2015
Q4
Sell
-21,207
Closed -$338K 4175
2015
Q3
$285K Sell
21,207
-53,337
-72% -$1.07M ﹤0.01% 2841
2015
Q2
$1.68M Buy
+74,544
New +$1.31M 0.01% 1117
2014
Q1
Sell
-15,436
Closed -$231K 2832
2013
Q4
$231K Sell
15,436
-35,201
-70% -$453K ﹤0.01% 1902
2013
Q3
$559K Sell
50,637
-81,638
-62% -$680K 0.01% 1615
2013
Q2
$1.05M Buy
+132,275
New +$842K 0.02% 857

Other funds holding HALO

Jane Street's HALO Position: Q2 2026 in Review

Jane Street reduced its Halozyme (HALO) stake by 16% in Q2 2026, selling an estimated $9.34M and leaving 694,684 shares worth $54.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1357.

Jane Street first reported a position in HALO in Q2 2013 and has held it in 40 quarters since. The position peaked at $78.9M in Q3 2025. 629 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Jane Street held 694,684 shares of Halozyme worth $54.4M as of Q2 2026.
  • Jane Street sold 137,023 Halozyme shares in Q2 2026, an estimated $9.34M.
  • Halozyme made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #1357 holding.
  • Jane Street first reported a position in Halozyme in Q2 2013 and has held it in 40 quarters since.
  • Jane Street's Halozyme position peaked at $78.9M in Q3 2025.
  • 629 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.